Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : biologics
Harbour BioMed Reports Positive Phase I Results for HBM9378 Antibody Therapy
03/23/2026 | Companies
antibody therapeutics,
biologics,
biotech innovation,
chronic obstructive pulmonary disease,
clinical research,
COPD,
drug development,
half-life extension,
Harbour BioMed,
HBM9378,
immune-oncology,
immunological disorders,
immunology,
Kelun-Biotech,
monoclonal antibody,
pharmacokinetics,
Phase I clinical trial,
respiratory medicine,
safety profile,
severe asthma,
SKB378,
TSLP inhibitor,
WIN378
Teva’s Global Innovation Strategy: Advancing Healthcare Through Collaboration and Research
06/18/2025 | Companies
academic partnerships,
academic research,
AI drug development,
AI in healthcare,
AION Labs,
BioInnovators Forum,
biologics,
biomarkers,
clinical trials,
disease burden,
drug discovery,
epidemiology,
healthcare access,
healthcare innovation,
IMI,
innovation,
Israeli biotech,
medical education,
neurodegenerative diseases,
Organospheres,
patient access,
pharmaceutical research,
pharmaceutical startups,
public health research,
public-private partnerships,
PubMed publications,
R&D,
scientific collaboration,
Teva Pharmaceuticals,
translational medicine,
unmet medical needs
Companies
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com